AMN Healthcare price target lowered to $105 from $115 at Credit Suisse

Credit Suisse lowered the firm’s price target on AMN Healthcare to $105 from $115 and keeps an Outperform rating on the shares. AMN’s Q2 results were slightly better than estimates, though the company reduced its revenue and EBITDA outlook for Q3, the analyst tells investors in a research note.